KromaTiD
PrivateLast Round
Series C
Aug 20, 2025
Total Funding Raised
$14.21M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KromaTiD is a biotechnology company that provides proprietary single-cell genomic structural analysis products and services to support cell and gene therapy development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KromaTiD Comparables
Compare KromaTiD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionano Genomics Inc | 79% | |
| Creative Biolabs | 76% | |
| MaxCyte Inc | 71% |
KromaTiD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 20, 2025 | ||||
| Corporate Funding | Apr 21, 2021 | ||||
| Series A | Aug 13, 2019 | ||||
| Grant | Jun 10, 2019 |
KromaTiD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| First Capital Ventures | Series A |
| BroadOak Capital Partners | Series C, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 108% MoM, reaching 2.8K.
- Aug 20, 2025
$8M round led by BroadOak Capital Partners.
KromaTiD Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KromaTiD's valuation, stock price, and market status.
Is KromaTiD a public or private company?
KromaTiD is a private company.
What is the current stock price of KromaTiD?
KromaTiD is a private company with no public stock price. No recent secondary market data is available.
How much is KromaTiD worth (valuation)?
Valuation information for KromaTiD is not publicly available.
Can I buy KromaTiD stock?
KromaTiD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KromaTiD's last funding round?
KromaTiD's most recent funding round was Series C on August 20, 2025.
Who are the main investors in KromaTiD?
Key investors in KromaTiD include First Capital Ventures, BroadOak Capital Partners.
Will KromaTiD IPO soon?
No public IPO plans have been announced for KromaTiD.
How can I track KromaTiD secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KromaTiD's secondary market activity and sign up for updates.